1Fisher B,Jeong JH,Bryant J,et al.Treat-ment of lymph-node-negative,oestrogen-receptor-positive breast cancer:long-term findings from Na-tional Surgical Adjuvant Breast and Bowel Project randomised clinical trials[].The Lancet.2004
2Goldhirsch A,Glick JH,Gelber RD,et al.Meeting Highlights:International Expert Consensus on the Primary Therapy of Early Breast Cancer2005[].Annals of Oncology.2005
3Mano MS,Awada A,Kerr J,et al.Adjuvant anthracycline-based chemotherapy for early breast cancer:do the dose and schedule matter[].Cancer Treatment Reviews.2005
4Fisher ER,Wang J,Bryant J,et al.Pathobiology of preoperative chemotherapy:find-ings from the National Surgical Adjuvant Breast and Bowel(NSABP)protocol B-18[].Cancer.2002
5Bonneterre J,Roche H,Kerbrat P,et al.Epirubicin Increases Long-Term Survival in Adju-vant Chemotherapy of Patients With Poor-Prognosis,Node-Positive,Early Breast Cancer:10-Year Follow-Up Results of the French Adjuvant Study Group05Randomized Trial[].Journal of Clinical Oncology.2005
6Bonadonna G,Molitemi A,Zambetti M,et al.30years’follow up of randomized studies of adju-vant CMF in operable breast cancer:cohort study[].British Medical Journal.2005
